Hypertrophic Cardiomyopathy

As per available reports about 200 journals, 162 Conferences, 25 workshops are presently dedicated exclusively to cardiology and about 15322 articles are being published on the current trends in hypertrophic cardiomyopathy. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to hypertrophic cardiomyopathy are being carried out. As reported in Clinical Implication of Genetic Testing for Hypertrophic Cardiomyopathy article, hypertrophic cardiomyopathy is caused by a dominant mutation of the sarcomere protein gene in approximately 60% of cases. The root word “cardiomyopathy” refers to diseases of the heart muscle. Hypertrophic cardiomyopathy can be treated by using medications.

The Journal of Cardiovascular Diseases & Diagnosis is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in hypertrophic cardiomyopathy. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Cardiovascular Diseases & Diagnosis provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of cardiology, thus bridging the gap between researchers and young scientists.

OMICS International- a pioneer in organizing international conferences in USA, Europe, Asia and other countries. This will reflect the scope in current research and development in science, healthcare and technology. 5th International Conference on Clinical & Experimental Cardiology is being held during April 27-29, 2015 at Philadelphia, USA. Cardiology International conference is designed to provide diverse and current education that will keep medical professionals abreast of the issues affecting the prevention, diagnosis and treatment of cardiovascular disease.